Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balkrishen Bhat

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Antimicrobial Agents and Chemotherapy|April 28, 2005
Inhibitory effect of 2'-substituted nucleosides on hepatitis C virus replication correlates with metabolic properties in replicon cellsJoanne E Tomassini, Krista Getty, Mark W Stahlhut, et al.
Scientific Reports|December 16, 2015
A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditionsThomas Bertero, Katherine A Cottrill, Sofia Annis, et al.
Journal of Medicinal Chemistry|February 18, 2005
Synthesis and evaluation of S-acyl-2-thioethyl esters of modified nucleoside 5'-monophosphates as inhibitors of hepatitis C virus RNA replicationThazha P Prakash, Marija Prhavc, Anne B Eldrup, et al.
Bioorganic & Medicinal Chemistry|November 3, 2004
Synthesis and biological evaluation of 5R- and 5S-methyl substituted D- and L-configuration 1,3-dioxolane nucleoside analogsSanjib Bera, Leila Malik, Balkrishen Bhat, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2017
Gene activation of SMN by selective disruption of lncRNA-mediated recruitment of PRC2 for the treatment of spinal muscular atrophyCaroline J Woo, Verena K Maier, Roshni Davey, et al.
The Journal of Clinical Investigation|December 17, 2013
Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activityChinavenmeni S Velu, Aditya Chaubey, James D Phelan, et al.
The Journal of Biological Chemistry|January 30, 2003
Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogsSteven S Carroll, Joanne E Tomassini, Michele Bosserman, et al.
Journal of Medicinal Chemistry|April 16, 2004
Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymeraseAnne B Eldrup, Charles R Allerson, C Frank Bennett, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2004
A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic propertiesDavid B Olsen, Anne B Eldrup, Linda Bartholomew, et al.
The Journal of Clinical Investigation|June 25, 2014
Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertensionThomas Bertero, Yu Lu, Sofia Annis, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|April 28, 2005
Inhibitory effect of 2'-substituted nucleosides on hepatitis C virus replication correlates with metabolic properties in replicon cellsJoanne E Tomassini, Krista Getty, Mark W Stahlhut, et al.
Scientific Reports|December 16, 2015
A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditionsThomas Bertero, Katherine A Cottrill, Sofia Annis, et al.
Journal of Medicinal Chemistry|February 18, 2005
Synthesis and evaluation of S-acyl-2-thioethyl esters of modified nucleoside 5'-monophosphates as inhibitors of hepatitis C virus RNA replicationThazha P Prakash, Marija Prhavc, Anne B Eldrup, et al.
Bioorganic & Medicinal Chemistry|November 3, 2004
Synthesis and biological evaluation of 5R- and 5S-methyl substituted D- and L-configuration 1,3-dioxolane nucleoside analogsSanjib Bera, Leila Malik, Balkrishen Bhat, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2017
Gene activation of SMN by selective disruption of lncRNA-mediated recruitment of PRC2 for the treatment of spinal muscular atrophyCaroline J Woo, Verena K Maier, Roshni Davey, et al.
The Journal of Clinical Investigation|December 17, 2013
Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activityChinavenmeni S Velu, Aditya Chaubey, James D Phelan, et al.
The Journal of Biological Chemistry|January 30, 2003
Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogsSteven S Carroll, Joanne E Tomassini, Michele Bosserman, et al.
Journal of Medicinal Chemistry|April 16, 2004
Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymeraseAnne B Eldrup, Charles R Allerson, C Frank Bennett, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2004
A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic propertiesDavid B Olsen, Anne B Eldrup, Linda Bartholomew, et al.
The Journal of Clinical Investigation|June 25, 2014
Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertensionThomas Bertero, Yu Lu, Sofia Annis, et al.
Pageof 5